vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Kennedy-Wilson Holdings, Inc. (KW). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $120.6M, roughly 1.7× Kennedy-Wilson Holdings, Inc.). Kennedy-Wilson Holdings, Inc. runs the higher net margin — 48.1% vs 8.3%, a 39.8% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -11.0%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-55.2M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -6.0%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Kennedy Wilson is a real estate investment company headquartered in Beverly Hills, California, United States.
COLL vs KW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $120.6M |
| Net Profit | $17.0M | $58.0M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | 57.3% |
| Net Margin | 8.3% | 48.1% |
| Revenue YoY | 12.9% | -11.0% |
| Net Profit YoY | 35.3% | 32.7% |
| EPS (diluted) | $0.48 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $120.6M | ||
| Q3 25 | $209.4M | $116.4M | ||
| Q2 25 | $188.0M | $135.7M | ||
| Q1 25 | $177.8M | $128.3M | ||
| Q4 24 | $181.9M | $135.5M | ||
| Q3 24 | $159.3M | $127.5M | ||
| Q2 24 | $145.3M | $132.0M | ||
| Q1 24 | $144.9M | $136.4M |
| Q4 25 | $17.0M | $58.0M | ||
| Q3 25 | $31.5M | $-10.2M | ||
| Q2 25 | $12.0M | $5.6M | ||
| Q1 25 | $2.4M | $-29.6M | ||
| Q4 24 | $12.5M | $43.7M | ||
| Q3 24 | $9.3M | $-66.8M | ||
| Q2 24 | $19.6M | $-48.3M | ||
| Q1 24 | $27.7M | $37.7M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | 57.3% | ||
| Q3 25 | 29.7% | -6.2% | ||
| Q2 25 | 18.7% | 7.4% | ||
| Q1 25 | 12.2% | -26.9% | ||
| Q4 24 | 20.9% | 36.7% | ||
| Q3 24 | 21.9% | -60.8% | ||
| Q2 24 | 32.7% | -45.5% | ||
| Q1 24 | 34.1% | 47.2% |
| Q4 25 | 8.3% | 48.1% | ||
| Q3 25 | 15.0% | -8.8% | ||
| Q2 25 | 6.4% | 4.1% | ||
| Q1 25 | 1.4% | -23.1% | ||
| Q4 24 | 6.9% | 32.3% | ||
| Q3 24 | 5.9% | -52.4% | ||
| Q2 24 | 13.5% | -36.6% | ||
| Q1 24 | 19.1% | 27.6% |
| Q4 25 | $0.48 | $0.22 | ||
| Q3 25 | $0.84 | $-0.15 | ||
| Q2 25 | $0.34 | $-0.05 | ||
| Q1 25 | $0.07 | $-0.30 | ||
| Q4 24 | $0.36 | $0.24 | ||
| Q3 24 | $0.27 | $-0.56 | ||
| Q2 24 | $0.52 | $-0.43 | ||
| Q1 24 | $0.71 | $0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $184.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $1.5B |
| Total Assets | $1.7B | $6.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $184.5M | ||
| Q3 25 | $285.9M | $382.6M | ||
| Q2 25 | $222.2M | $309.1M | ||
| Q1 25 | $197.8M | $356.6M | ||
| Q4 24 | $162.8M | $217.5M | ||
| Q3 24 | $120.0M | $367.1M | ||
| Q2 24 | $271.6M | $366.5M | ||
| Q1 24 | $318.0M | $541.9M |
| Q4 25 | $301.7M | $1.5B | ||
| Q3 25 | $274.8M | $1.5B | ||
| Q2 25 | $232.2M | $1.6B | ||
| Q1 25 | $234.4M | $1.6B | ||
| Q4 24 | $228.8M | $1.6B | ||
| Q3 24 | $234.3M | $1.6B | ||
| Q2 24 | $216.6M | $1.7B | ||
| Q1 24 | $222.2M | $1.7B |
| Q4 25 | $1.7B | $6.6B | ||
| Q3 25 | $1.6B | $6.7B | ||
| Q2 25 | $1.6B | $6.8B | ||
| Q1 25 | $1.6B | $7.2B | ||
| Q4 24 | $1.7B | $7.0B | ||
| Q3 24 | $1.6B | $7.4B | ||
| Q2 24 | $1.1B | $7.5B | ||
| Q1 24 | $1.1B | $7.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $11.4M |
| Free Cash FlowOCF − Capex | $122.4M | $-55.2M |
| FCF MarginFCF / Revenue | 59.6% | -45.8% |
| Capex IntensityCapex / Revenue | 0.3% | 55.2% |
| Cash ConversionOCF / Net Profit | 7.25× | 0.20× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $-103.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $11.4M | ||
| Q3 25 | $78.4M | $-7.6M | ||
| Q2 25 | $72.4M | $42.0M | ||
| Q1 25 | $55.4M | $-51.9M | ||
| Q4 24 | $84.6M | $55.1M | ||
| Q3 24 | $-9.0M | $-5.6M | ||
| Q2 24 | $67.4M | $36.7M | ||
| Q1 24 | $61.9M | $-5.6M |
| Q4 25 | $122.4M | $-55.2M | ||
| Q3 25 | $78.3M | $-18.0M | ||
| Q2 25 | $72.4M | $29.4M | ||
| Q1 25 | $54.6M | $-59.7M | ||
| Q4 24 | $84.1M | $-76.5M | ||
| Q3 24 | $-9.2M | $-27.7M | ||
| Q2 24 | $67.1M | $-500.0K | ||
| Q1 24 | $61.4M | $-57.1M |
| Q4 25 | 59.6% | -45.8% | ||
| Q3 25 | 37.4% | -15.5% | ||
| Q2 25 | 38.5% | 21.7% | ||
| Q1 25 | 30.7% | -46.5% | ||
| Q4 24 | 46.2% | -56.5% | ||
| Q3 24 | -5.8% | -21.7% | ||
| Q2 24 | 46.2% | -0.4% | ||
| Q1 24 | 42.3% | -41.9% |
| Q4 25 | 0.3% | 55.2% | ||
| Q3 25 | 0.1% | 8.9% | ||
| Q2 25 | 0.0% | 9.3% | ||
| Q1 25 | 0.4% | 6.1% | ||
| Q4 24 | 0.3% | 97.1% | ||
| Q3 24 | 0.2% | 17.3% | ||
| Q2 24 | 0.2% | 28.2% | ||
| Q1 24 | 0.4% | 37.8% |
| Q4 25 | 7.25× | 0.20× | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | 7.50× | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | 1.26× | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | -0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
KW
| Consolidated Portfolio Segment | $84.9M | 70% |
| Investment Management Fees | $30.4M | 25% |
| Real Estate | $5.1M | 4% |
